FPF
NXTM

FNY Partners Fund’s NxStage Medical Inc. NXTM Stock Holding History

FNY Partners Fund’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$211K Sell
8,500
-3,900
-31% -$94.9K 0.11% 100
2017
Q4 		$300K Buy
+12,400
New +$327K 0.05% 119

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FNY Partners Fund's NXTM Position: Q1 2018 in Review

FNY Partners Fund reduced its NxStage Medical Inc. (NXTM) stake by 31% in Q1 2018, selling an estimated $94.9K and leaving 8,500 shares worth $211K. The position accounts for 0.11% of the portfolio, ranked #100.

FNY Partners Fund first reported a position in NXTM in Q4 2017 and has held it in 2 quarters since. The position peaked at $300K in Q4 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q1 2018.

  • FNY Partners Fund held 8,500 shares of NxStage Medical Inc. worth $211K as of Q1 2018.
  • FNY Partners Fund sold 3,900 NxStage Medical Inc. shares in Q1 2018, an estimated $94.9K.
  • NxStage Medical Inc. made up 0.11% of FNY Partners Fund's portfolio in Q1 2018, its #100 holding.
  • FNY Partners Fund first reported a position in NxStage Medical Inc. in Q4 2017 and has held it in 2 quarters since.
  • FNY Partners Fund's NxStage Medical Inc. position peaked at $300K in Q4 2017.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.